世界の埋め込み型遠隔患者モニタリングデバイス市場

Global Implantable Remote Patient Monitoring Devices Market

世界の埋め込み型遠隔患者モニタリングデバイス市場

商品番号 : SMB-76749

出版社BCC Research
出版年月2025年4月
ページ数140
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

Report Highlights

The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.

埋め込み型遠隔患者モニタリング(IRPM)デバイスの世界市場は、2023年に65億ドルと評価されました。この市場は、2024年の76億ドルから2029年末には203億ドルに成長し、2024年から2029年にかけて年平均成長率(CAGR)は21.7%になると予想されています。

Report Scope

The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.

本レポートは、市場の埋め込み型遠隔患者モニタリング(IRPM)デバイスに関する詳細情報を提供しています。2029年までの市場予測と主要企業の市場ランキングを提供しています。レポートでは、製品、適応症、エンドユーザーに基づいて、IRPMデバイスの市場シェアを詳述しています。この市場は、製品に基づいて、埋め込み型心血管モニタリングデバイス、埋め込み型脳モニタリングデバイス、胃腸モニタリング(スマートピル)、埋め込み型血液モニタリングデバイス、埋め込み型呼吸モニタリングデバイス、埋め込み型筋骨格モニタリングデバイス、その他に分類されています。適応症に基づいて、市場は心血管疾患、脳疾患、胃腸疾患、糖尿病、慢性呼吸器疾患、筋骨格疾患、その他に分類されています。エンドユーザー別には、市場は病院や診療所、在宅医療環境、その他に分類されています。詳細な競争環境には、主要プレーヤー、市場シェア、および最近の戦略的開発が含まれます。

Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2024-2029
Base year market size$6.5 Billion
Market size forecast$20.3 Billion
Growth rateCAGR of 21.7% from 2024 to 2029
Units considered$ Millions
Segments coveredBy Product, Disease Indication, End User, and Region
Regions coveredNorth America, Europe, Asia-Pacific, and the Rest of World (RoW)
Key Market Drivers
  • Increasing prevalence of chronic diseases and an aging population.
  • Growing demand for mHealth applications.
  • Improved wireless communication technologies.
Companies studied
ABBOTTAVERTIX MEDICAL INC.
BIOTRONIKBOSTON SCIENTIFIC CORP.
CARDIAC RMSDEXCOM INC.
EBR SYSTEMS INC.ENDOTRONIX INC.
INJECTSENSE INC.IMPULSE DYNAMICS
MEDICO S.R.L.MEDTRONIC
PROFUSA INC.QURA LLC.
VITALCONNECT

Report Includes

– 32 data tables and 47 additional tables

– An overview of the global market for implantable remote patient monitoring (IRPM) devices

– Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region

– Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases

– Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market

– Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts

– A discussion of the industry’s ESG challenges and practices

– Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management

– Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances

– Identification of the major stakeholders and analysis of recent developments and segmental revenues

– Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

PESTEL Analysis

Political

Economic

Social

Technological

Environmental

Legal

Porter’s Five Forces Analysis

Bargaining Power of Buyers

Bargaining Power of Suppliers

Potential for New Entrants

Threat of Substitutes

Competition in the Industry

Supply Chain Analysis

R&D, Product Design and Early Prototyping

Regulatory Submissions and Approvals

Raw Material Procurement

Manufacturing IRPM Devices

Distribution and Sales

Post-Sales Services

Chapter 3 Market Dynamics

Market Dynamics Overview

Market Drivers

Increasing Prevalence of Chronic Diseases and an Aging Population

Growing Demand for mHealth Applications

Improved Wireless Communication Technologies

Market Restraints

Data Privacy Concerns

Stringent Government Regulations

Market Opportunities

Emerging Markets

Market Challenges

Integration with Healthcare Systems

Chapter 4 Regulatory Landscape

Regulatory Framework

United States

European Union

Japan

Chapter 5 Emerging Technologies and Developments

Emerging Technologies in the IRPM Devices Market

Artificial Intelligence and Machine Learning

Nanotechnology-based Devices

Biocompatible Materials

Patent Analysis

Patents by Year

Patents by Top Applicant

Patents by Top Owner

Patents by Top Inventor

Patents by Jurisdiction

Chapter 6 Market Segment Analysis

Segmentation Breakdown

IRPM Devices: Global Markets

Market Analysis by Product

Implantable Cardiovascular Monitoring Devices

Implantable Brain Monitoring Devices

Gastrointestinal Monitoring (Smart Pills)

Implantable Hematological Monitoring Devices

Implantable Respiratory Monitoring Devices

Implantable Musculoskeletal Monitoring Devices

Others

Market Analysis by Indication

Cardiovascular Diseases

Brain Disorders

Gastrointestinal Diseases

Diabetes

Chronic Respiratory Diseases

Musculoskeletal Diseases

Others

Market Analysis by End User

Hospital and Clinics

Home Healthcare Settings

Other End-users

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 7 Sustainability: An ESG Perspective in IRPM Devices

Sustainability in the IRPM Devices Industry

Understanding the ESG Data

Concluding Remarks from BCC

Chapter 8 Competitive Intelligence

Overview

Key Strategies for IRPM Devices Manufacturers

Distribution Networks

Product Mapping

Chapter 9 Appendix

Methodology

Abbreviations

Sources

Company Profiles

ABBOTT

AVERTIX MEDICAL INC.

BIOTRONIK

BOSTON SCIENTIFIC CORP.

CARDIAC RMS

DEXCOM INC.

EBR SYSTEMS INC.

ENDOTRONIX INC.

INJECTSENSE INC.

IMPULSE DYNAMICS

MEDICO S.R.L.

MEDTRONIC

PROFUSA INC.

QURA LLC.

VITALCONNECT

List of Tables

Summary Table : Global Market for Implantable Remote Patient Monitoring Devices, by Region, Through 2029

Table 1 : Worldwide Diabetes Population, by WHO Region, 2021-2045

Table 2 : Global Elderly Population, by Country, 2022 and 2023

Table 3 : Notified Regulatory Bodies, By Country

Table 4 : Patents Granted for IRPM Devices, by Top Applicant, 2021-2024

Table 5 : Patents Granted for Implantable Remote Patient Monitoring Devices, by Top Owner, 2021–2024

Table 6 : Patents Granted for IRPM Devices, by Top Inventor, 2021-2024

Table 7 : Patents Granted for IRPM Devices, by Jurisdiction, 2021-2024

Table 8 : Global Market for IRPM Devices, Through 2029

Table 9 : Global Market for IRPM Devices, by Product, Through 2029

Table 10 : Smart Pills

Table 11 : Global Market for IRPM Devices, by Indication, Through 2029

Table 12 : Global Market for IRPM Devices, by End User, Through 2029

Table 13 : Global Market for IRPM Devices, by Region, Through 2029

Table 14 : North American Market for IRPM Devices, by Country, Through 2029

Table 15 : North American Market for Implantable Remote Patient Monitoring Devices, by Product, Through 2029

Table 16 : North American Market for IRPM Devices, by Indication, Through 2029

Table 17 : North American Market for IRPM Devices, by End User, Through 2029

Table 18 : European Market for IRPM Devices, by Country, Through 2029

Table 19 : European Market for IRPM Devices, by Product, Through 2029

Table 20 : European Market for IRPM Devices, by Indication, Through 2029

Table 21 : European Market for IRPM Devices, by End User, Through 2029

Table 22 : Asia-Pacific Market for IRPM Devices, by Country, Through 2029

Table 23 : Asia-Pacific Market for IRPM Devices, by Product, Through 2029

Table 24 : Asia-Pacific Market for IRPM Devices, by Indication, Through 2029

Table 25 : Asia-Pacific Market for IRPM Devices, by End User, Through 2029

Table 26 : RoW Market for IRPM Devices, by Product, Through 2029

Table 27 : RoW Market for IRPM Devices, by Indication, Through 2029

Table 28 : RoW Market for IRPM Devices, by End User, Through 2029

Table 29 : ESG Rankings for Major IRPM Devices Companies, 2024*

Table 30 : IRPM Devices: Major Players

Table 31 : Implantable Cardiovascular Monitoring Device Product Mapping

Table 32 : Glossary of Terms Used in Global Market for Implantable Remote Patient Monitoring Devices

Table 33 : Information Sources for this Report

Table 34 : Abbott: Company Snapshot

Table 35 : Abbott: Financial Performance, FY 2022 and 2023

Table 36 : Abbott: Product Portfolio

Table 37 : Abbott: News/Key Developments, 2023 and 2024

Table 38 : Avertix Medical Inc.: Company Snapshot

Table 39 : Avertix Medical Inc.: Product Portfolio

Table 40 : Avertix Medical Inc.: News/Key Developments, 2023

Table 41 : Biotronik: Company Snapshot

Table 42 : Biotronik: Product Portfolio

Table 43 : Biotronik: News/Key Developments, 2023

Table 44 : Boston Scientific Corp.: Company Snapshot

Table 45 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023

Table 46 : Boston Scientific Corp.: Product Portfolio

Table 47 : Boston Scientific Corp.: News/Key Developments, 2024

Table 48 : Cardiac RMS: Company Snapshot

Table 49 : Cardiac RMS: Product Portfolio

Table 50 : Dexcom Inc.: Company Snapshot

Table 51 : Dexcom Inc.: Financial Performance, FY 2022 and 2023

Table 52 : Dexcom Inc.: Product Portfolio

Table 53 : Dexcom Inc.: News/Key Developments, 2024

Table 54 : EBR Systems Inc.: Company Snapshot

Table 55 : EBR Systems Inc.: Financial Performance, FY 2022 and 2023

Table 56 : EBR Systems Inc.: Product Portfolio

Table 57 : EBR Systems Inc.: News/Key Developments, 2024

Table 58 : Endotronix Inc.: Company Snapshot

Table 59 : Endotronix Inc.: Product Portfolio

Table 60 : Endotronix Inc.: News/Key Developments, 2024

Table 61 : InjectSense Inc.: Company Snapshot

Table 62 : InjectSense Inc.: Product Portfolio

Table 63 : InjectSense Inc.: News/Key Developments, 2024

Table 64 : Impulse Dynamics: Company Snapshot

Table 65 : Impulse Dynamics: Product Portfolio

Table 66 : Impulse Dynamics: News/Key Developments, 2024

Table 67 : Medico S.R.L.: Company Snapshot

Table 68 : Medico S.R.L.: Product Portfolio

Table 69 : Medtronic: Company Snapshot

Table 70 : Medtronic: Financial Performance, FY 2022 and 2023

Table 71 : Medtronic: Product Portfolio

Table 72 : Medtronic: News/Key Developments, 2023 and 2024

Table 73 : Profusa Inc.: Company Snapshot

Table 74 : Profusa Inc.: Product Portfolio

Table 75 : Qura LLC.: Company Snapshot

Table 76 : Qura LLC.: Product Portfolio

Table 77 : VitalConnect: Company Snapshot

Table 78 : VitalConnect: Product Portfolio

List of Figures

Summary Figure : Global Market for Implantable Remote Patient Monitoring Devices, by Region, 2021–2029

Figure 1 : Supply Chain Analysis of Implantable Remote Patient Monitoring Devices Industry

Figure 2 : Market Dynamics of IRPM Devices Market

Figure 3 : Emerging Trends and Technologies in IRPM Devices

Figure 4 : Patents Granted for IRPM Devices, by Year, 2021–2024

Figure 5 : Share of Global Market for IRPM Devices, by Product, 2023

Figure 6 : Share of Global Market for IRPM Devices, by Indication, 2023

Figure 7 : Share of Global Market for IRPM Devices, by End User, 2023

Figure 8 : Share of Global Market for IRPM Devices, by Region, 2023

Figure 9 : Share of North American Market for IRPM Devices, by Country, 2023

Figure 10 : North American Market for IRPM Devices, 2021–2029

Figure 11 : Share of North American Market for IRPM Devices, by Product, 2023

Figure 12 : Share of North American Market for IRPM Devices, by Indication, 2023

Figure 13 : Share of North American Market for IRPM Devices, by End User, 2023

Figure 14 : Share of European Market for IRPM Devices, by Country, 2023

Figure 15 : European Market for IRPM Devices, 2021–2029

Figure 16 : Share of European Market for IRPM Devices, by Product, 2023

Figure 17 : Share of European Market for IRPM Devices, by Indication, 2023

Figure 18 : Share of European Market for IRPM Devices, by End User, 2023

Figure 19 : Share of Asia-Pacific Market for IRPM Devices, by Country, 2023

Figure 20 : Asia-Pacific Market for IRPM Devices, 2021–2029

Figure 21 : Share of Asia-Pacific Market for IRPM Devices, by Product, 2023

Figure 22 : Share of Asia-Pacific Market for IRPM Devices, by Indication, 2023

Figure 23 : Share of Asia-Pacific Market for IRPM Devices, by End User, 2023

Figure 24 : RoW Market for IRPM Devices, 2021–2029

Figure 25 : Share of RoW Market for IRPM Devices, by Product, 2023

Figure 26 : Share of RoW Market for IRPM Devices, by Indication, 2023

Figure 27 : Share of RoW Market for IRPM Devices, by End User, 2023

Figure 28 : Key ESG Metrics for Companies in the IRPM Devices Industry

Figure 29 : Abbott: Revenue Share, by Business Unit, FY 2023

Figure 30 : Abbott: Revenue Share, by Country/Region, FY 2023

Figure 31 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023

Figure 32 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023

Figure 33 : Dexcom Inc.: Revenue Share, by Sales Channel, FY 2023

Figure 34 : Dexcom Inc.: Revenue Share, by Country/Region, FY 2023

Figure 35 : Medtronic: Revenue Share, by Business Unit, FY 2023

Figure 36 : Medtronic: Revenue Share, by Country/Region, FY 2023